Aqr Capital Management LLC Olema Pharmaceuticals, Inc. Transaction History

Aqr Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$8.73 - $13.99 $6,145 - $9,848	704 Added 6.16%	12,125 $131,000
Q1 2024 May 15, 2024	BUY	$10.95 - $16.62 $7,008 - $10,636	640 Added 5.94%	11,421 $129,000
Q4 2023 Feb 14, 2024	BUY	$10.53 - $17.14 $7,665 - $12,477	728 Added 7.24%	10,781 $151,000
Q3 2023 Nov 14, 2023	BUY	$8.19 - $12.98 $82,334 - $130,487	10,053 New	10,053 $124,000
Q2 2022 Aug 15, 2022	BUY	$2.04 - $4.61 $60,092 - $135,796	29,457 Added 70.95%	70,973 $289,000
Q1 2022 May 16, 2022	BUY	$3.89 - $9.43 $161,497 - $391,495	41,516 New	41,516 $177,000

136

58.8M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $217M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.